Sale!

RET Gene Selective Sequencing of Exons 5, 8, 10, 11 and 13-16 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The RET Gene Selective Sequencing NGS DNA Test is a comprehensive genetic analysis that examines specific exons (5, 8, 10, 11 and 13-16) of the RET proto-oncogene using Next Generation Sequencing technology. This advanced test helps identify mutations associated with multiple endocrine neoplasia type 2 (MEN2), familial medullary thyroid carcinoma, and other hereditary cancer syndromes. By detecting specific RET gene alterations, this test provides crucial information for cancer risk assessment, early intervention planning, and personalized treatment strategies. The test costs $500 USD and is particularly valuable for individuals with family history of thyroid cancer or endocrine tumors. Results typically take 3-4 weeks and require a simple blood sample or DNA extraction.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

RET Gene Selective Sequencing of Exons 5, 8, 10, 11 and 13-16 NGS Genetic DNA Test

Comprehensive Introduction to RET Gene Testing

The RET Gene Selective Sequencing NGS DNA Test represents a cutting-edge approach to cancer genetic testing, specifically targeting the RET proto-oncogene—a critical gene involved in cell growth and development. This specialized test focuses on sequencing specific exons (5, 8, 10, 11 and 13-16) that are known hotspots for mutations associated with hereditary cancer syndromes. Using Next Generation Sequencing technology, this test provides unprecedented accuracy in detecting genetic variations that could significantly impact your cancer risk assessment and management strategies.

What This Advanced Genetic Test Measures

Our RET Gene Selective Sequencing test specifically analyzes:

  • Exon 5: Associated with early-onset familial medullary thyroid carcinoma
  • Exon 8: Critical for receptor tyrosine kinase function
  • Exon 10: Known hotspot for MEN2A-associated mutations
  • Exon 11: Important for ligand binding domain integrity
  • Exons 13-16: Contain crucial tyrosine kinase domains affected in MEN2B

The test identifies point mutations, insertions, deletions, and other genetic variations within these specific exons that are clinically significant for cancer predisposition.

Who Should Consider RET Gene Testing

Clinical Indications and Symptoms

This test is particularly recommended for individuals with:

  • Personal history of medullary thyroid carcinoma at any age
  • Family history of multiple endocrine neoplasia type 2 (MEN2)
  • Diagnosis of pheochromocytoma or parathyroid tumors
  • Mucosal neuromas or marfanoid habitus suggestive of MEN2B
  • Elevated calcitonin levels without obvious thyroid pathology
  • First-degree relatives of known RET mutation carriers
  • Unexplained endocrine tumors in multiple family members

Significant Benefits of RET Gene Testing

Undergoing RET gene sequencing provides numerous advantages:

  • Early Risk Assessment: Identify cancer predisposition before symptoms develop
  • Personalized Screening: Tailor surveillance protocols based on genetic risk
  • Family Planning: Make informed decisions about genetic inheritance
  • Treatment Guidance: Inform surgical and medical management decisions
  • Prophylactic Interventions: Enable preventive measures for at-risk individuals
  • Psychological Relief: Reduce uncertainty through definitive genetic information

Understanding Your Test Results

Interpretation Guidance

Your RET gene test results will fall into one of several categories:

  • Positive for Pathogenic Mutation: Indicates increased cancer risk requiring specialized management and family testing
  • Negative Result: No known disease-causing mutations detected in tested exons
  • Variant of Uncertain Significance (VUS): Genetic change with unknown clinical impact requiring ongoing monitoring
  • Benign Polymorphism: Common genetic variation not associated with increased cancer risk

All results are accompanied by comprehensive genetic counseling to ensure proper understanding and appropriate next steps.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have conveniently located branches across the United States, serving major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing regardless of location.

Take Action for Your Genetic Health

Don’t wait to gain crucial insights into your cancer risk profile. Our comprehensive RET gene testing provides the information you need to make informed healthcare decisions. With a simple blood draw or DNA sample, you can access advanced genetic analysis that could significantly impact your long-term health outcomes.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment and begin your journey toward personalized cancer risk management.

Our genetic counseling team is available to discuss your family history, explain the testing process, and help you understand how RET gene testing can benefit you and your family members. Take the first step toward proactive genetic health management today.